(1 - 11 von 16
)
Novo Nordisk builds in haemophilia with Bluebird Bio gene editing...
pharmaphorum.com
Bluebird Bio and Novo Nordisk partner on in vivo genome editing approach to a ‘once-and-done’ therapy for haemophilia and other genetic diseases
sortiert nach Relevanz / Datum